The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Active surveillance for early‐stage prostate cancer: Review of the current literature
Open accessAbstract
The natural history of prostate cancer is remarkably heterogeneous and, at this time, not completely understood. The widespread adoption and application of prostate‐specific antigen (PSA) screening has led to a dramatic shift toward the diagnosis of low‐volume, nonpalpable, early‐stage tumors. Autopsy and early observational studies have shown that approximately 1 in 3 men aged >50 years has histologic evidence of prostate cancer, with a significant portion of tumors being small and possibly clinically insignificant. Utilizing the power of improved contemporary risk stratification schema to better identify patients with a low risk of cancer progression, several centers are gaining considerable experience with active surveillance and delayed, selective, and curative therapy. A literature review was performed to evaluate the rationale behind active surveillance for prostate cancer and to describe the early experiences from surveillance protocols. It appears that a limited number of men on active surveillance have required treatment, with the majority of such men having good outcomes after delayed selective intervention for progressive disease. The best candidates for active surveillance are being defined, as are predictors of active treatment. The psychosocial ramifications of surveillance for prostate cancer can be profound and future needs and unmet goals will be discussed. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
D'Amico, A. V. (1998) · JAMA · doi:10.1001/jama.280.11.969 · Cited by 4,523
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Sathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Freedland, S. J., Humphreys, E. B., Mangold, L. A., Eisenberger, M., Dorey, F. J., Walsh, P. C., & Partin, A. W. (2005) · JAMA · doi:10.1001/jama.294.4.433 · Cited by 1,358
A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
Kattan, M. W., Eastham, J. A., Stapleton, A. M. F., Wheeler, T. M., & Scardino, P. T. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.10.766 · Cited by 1,242
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
Self-citationDraisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A. M., Schroder, F. H., & de Koning, H. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.868 · Cited by 1,071
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
Partin, A. W., Mangold, L. A., Lamm, D. M., Walsh, P. C., Epstein, J. I., & Pearson, J. D. (2001) · Urology · doi:10.1016/s0090-4295(01)01441-8 · Cited by 1,038
Etzioni, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.981 · Cited by 949
COOPERBERG, M. R., PASTA, D. J., ELKIN, E. P., LITWIN, M. S., LATINI, D. M., Du CHANE, J., & CARROLL, P. R. (2005) · Journal of Urology · doi:10.1097/01.ju.0000158155.33890.e7 · Cited by 772
Self-citationPreoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
D'Amico, A. V., Chen, M.-H., Roehl, K. A., & Catalona, W. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032975 · Cited by 740
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Christianity and Democracy: The Global Picture
Berger, P. L. (2004) · Journal of Democracy · doi:10.1353/jod.2004.0022 · Cited by 689
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
Self-citationCarter, H. B., Ferrucci, L., Kettermann, A., Landis, P., Wright, E. J., Epstein, J. I., Trock, B. J., & Metter, E. J. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj410 · Cited by 556
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00739-6 · Cited by 479
A COMPARATIVE ANALYSIS OF SEXTANT AND AN EXTENDED 11-CORE MULTISITE DIRECTED BIOPSY STRATEGY
BABAIAN, R. J., TOI, A., KAMOI, K., TRONCOSO, P., SWEET, J., EVANS, R., JOHNSTON, D., & CHEN, M. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67993-1 · Cited by 456
Wei, J. T., Dunn, R. L., Sandler, H. M., McLaughlin, P. W., Montie, J. E., Litwin, M. S., NYQUIST, L. V., & Sanda, M. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.557 · Cited by 443
Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment
Cooperberg, M. R., Broering, J. M., Kantoff, P. W., & Carroll, P. R. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.135 · Cited by 442
Self-citationKATTAN, M. W., EASTHAM, J. A., WHEELER, T. M., MARU, N., SCARDINO, P. T., ERBERSDOBLER, A., GRAEFEN, M., HULAND, H., KOH, H., SHARIAT, S. F., et al. (2003) · Journal of Urology · doi:10.1097/01.ju.0000091806.70171.41 · Cited by 350
Geographic pathology of latent prostatic carcinoma
Yatani, R., Chigusa, I., Akazaki, K., Stemmermann, G. N., Welsh, R. A., & Correa, P. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290602 · Cited by 325
Latini, D. M., Hart, S. L., Knight, S. J., Cowan, J. E., Ross, P. L., DuChane, J., Carroll, P. R., & CaPSURE Investigators (2007) · Journal of Urology · doi:10.1016/j.juro.2007.05.039 · Cited by 223
Self-citationDelayed Versus Immediate Surgical Intervention and Prostate Cancer Outcome
Warlick, C., Trock, B. J., Landis, P., Epstein, J. I., & Carter, H. B. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj072 · Cited by 219
Self-citationLoeb, S., Roehl, K. A., Antenor, J. A. V., Catalona, W. J., Suarez, B. K., & Nadler, R. B. (2006) · Urology · doi:10.1016/j.urology.2005.08.040 · Cited by 184
Paris, P. L., Andaya, A., Fridlyand, J., Jain, A. N., Weinberg, V., Kowbel, D., Brebner, J. H., Simko, J., Watson, J. E. V., Volik, S., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh155 · Cited by 181
Self-citationTsai, H. K., Chen, M., McLeod, D. G., Carroll, P. R., Richie, J. P., & D'Amico, A. V. (2006) · Cancer · doi:10.1002/cncr.22279 · Cited by 166
Self-citationRoemeling, S., Roobol, M. J., de Vries, S. H., Wolters, T., Gosselaar, C., van Leenders, G. J. L. H., & Schröder, F. H. (2007) · European Urology · doi:10.1016/j.eururo.2006.11.053 · Cited by 160
Ali, K., Gunnar, A., Jan‐Erik, D., Lilja, H. G., Pär, L., & Jonas, H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22161 · Cited by 157
Uncertainty Intervention for Watchful Waiting in Prostate Cancer
Bailey, D. E., Mishel, M. H., Belyea, M. J., Stewart, J. L., & Mohler, J. L. (2004) · Cancer Nursing · doi:10.1097/00002820-200409000-00001 · Cited by 142
Self-citationWatching, waiting and uncertainty in prostate cancer
Bailey, D. E., Wallace, M. E., & Mishel, M. H. (2007) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2005.01545.x · Cited by 126
Self-citationActive surveillance with selective delayed intervention for favorable risk prostate cancer
Klotz, L. H. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.07.002 · Cited by 119
Self-citationUncertainty and Quality of Life of Older Men Who Undergo Watchful Waiting for Prostate Cancer
Wallace, M. E. (2003) · Oncology nursing forum · doi:10.1188/03.onf.303-309 · Cited by 114
Self-citationIs ‘watchful waiting’ a real choice for men with prostate cancer? A qualitative study
Chapple, A., Ziébland, S., Herxheimer, A., McPherson, A., Shepperd, S., & Miller, R. A. (2002) · British Journal of Urology · doi:10.1046/j.1464-410x.2002.02846.x · Cited by 111
Defining Aggressive Prostate Cancer Using a 12-Gene Model
Bismar, T. A., Demichelis, F., Riva, A., Kim, R., Varambally, S., He, L., Kutok, J. L., Aster, J. C., Tang, J., Kuefer, R., et al. (2006) · Neoplasia · doi:10.1593/neo.05664 · Cited by 107
Litwin, M. S., Lubeck, D. P., Spitalny, G. M., Henning, J. M., & Carroll, P. R. (2002) · Cancer · doi:10.1002/cncr.10651 · Cited by 91
Self-citationKonety, B. R., Bird, V. Y., Deorah, S., & Dahmoush, L. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000177470.84735.55 · Cited by 91
Freedland, S. J., Kane, C. J., Amling, C. L., Aronson, W. J., Presti, J. C., Terris, M. K., & The SEARCH Database Study Group (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00646-4 · Cited by 81
Living With Untreated Localized Prostate Cancer: A Qualitative Analysis of Patient Narratives
Hedestig, O., Sandman, P., & Widmark, A. (2003) · Cancer Nursing · doi:10.1097/00002820-200302000-00008 · Cited by 68
KATZ, D., Koppie, T. M., Wu, D., Meng, M. V., Grossfeld, G. D., SADESKY, N., Lubeck, D. P., & Carroll, P. R. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64303-0 · Cited by 67
Self-citationPredictors of Treatment After Initial Surveillance in Men With Prostate Cancer: Results From CaPSURE
Meng, M. V., Elkin, E. P., Harlan, S. R., Mehta, S. S., Lubeck, D. P., & Carroll, P. R. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000094190.46523.b2 · Cited by 66
Self-citationGalbraith, M. E., Ramirez, J. M., & Pedro, L. W. (2001) · PubMed · Cited by 65
Klotz, L. H. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0124 · Cited by 44
Self-citationPorter, M. P., Stanford, J. L., & Lange, P. H. (2006) · The Prostate · doi:10.1002/pros.20417 · Cited by 31
Kawachi, M. H. (2007) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2007.0059 · Cited by 27
Warlick, C. A., Allaf, M. E., & Carter, H. B. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.07.004 · Cited by 19
Self-citation
Cited by
Changes in circulating microRNA levels associated with prostate cancer
Bryant, R. J., Pawlowski, T., Catto, J. W. F., Marsden, G., Vessella, R. L., Rhees, B., Kuslich, C., Visakorpi, T., & Hamdy, F. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.595 · Cited by 715
Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging
Hoeks, C. M. A., Barentsz, J. O., Hambrock, T., Yakar, D., Somford, D. M., Heijmink, S. W. T. P. J., Scheenen, T. W. J., Vos, P. C., Huisman, H., van Oort, I. M., et al. (2011) · Radiology · doi:10.1148/radiol.11091822 · Cited by 677
Prostate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, A. O., Stanford, J. L., Zietman, A., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.093 · Cited by 517
Self-citationRethinking Screening for Breast Cancer and Prostate Cancer
Esserman, L. (2009) · JAMA · doi:10.1001/jama.2009.1498 · Cited by 516
Outcomes of Localized Prostate Cancer Following Conservative Management
Lu-Yao, G. L. (2009) · JAMA · doi:10.1001/jama.2009.1348 · Cited by 430
Metadata
- Authors
- Dall'Era, M. A., Cooperberg, M. R., Chan, J. M., Davies, B. J., Albertsen, P. C., Klotz, L. H., Warlick, C. A., Holmberg, L., Bailey, D. E., Wallace, M. E., Kantoff, P. W., & Carroll, P. R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-02-27
- Volume
- 112
- Issue
- 8
- Pages
- 1650-1659
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1980710500
- Cited by
- 273
- References
- 48
- FWCI
- 31.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.